Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Change in Account Payables (2016 - 2026)

Catalyst Pharmaceuticals filings provide 17 years of Change in Account Payables readings, the most recent being -$4.1 million for Q1 2026.

  • On a quarterly basis, Change in Account Payables rose 24.93% to -$4.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$4.0 million, a 532.26% decrease, with the full-year FY2025 number at -$5.4 million, down 399.83% from a year prior.
  • Change in Account Payables hit -$4.1 million in Q1 2026 for Catalyst Pharmaceuticals, down from $2.1 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $10.2 million in Q4 2023 to a low of -$5.7 million in Q2 2025.
  • Median Change in Account Payables over the past 5 years was $214000.0 (2022), compared with a mean of $257823.5.
  • The widest YoY moves for Change in Account Payables: up 8937.5% in 2022, down 873.7% in 2022.
  • Catalyst Pharmaceuticals' Change in Account Payables stood at $1.4 million in 2022, then soared by 605.19% to $10.2 million in 2023, then tumbled by 50.67% to $5.0 million in 2024, then crashed by 58.13% to $2.1 million in 2025, then plummeted by 292.36% to -$4.1 million in 2026.
  • The last three reported values for Change in Account Payables were -$4.1 million (Q1 2026), $2.1 million (Q4 2025), and $3.6 million (Q3 2025) per Business Quant data.